123 related articles for article (PubMed ID: 1676575)
1. Recombinant elastase inhibitors for therapy.
Schnebli HP
Ann N Y Acad Sci; 1991; 624():212-8. PubMed ID: 1676575
[No Abstract] [Full Text] [Related]
2. The potential role of elastase inhibitors in emphysema treatment.
Eriksson S
Eur Respir J; 1991 Oct; 4(9):1041-3. PubMed ID: 1684550
[No Abstract] [Full Text] [Related]
3. Different susceptibility of elastase inhibitors to inactivation by proteinases from Staphylococcus aureus and Pseudomonas aeruginosa.
Sponer M; Nick HP; Schnebli HP
Biol Chem Hoppe Seyler; 1991 Nov; 372(11):963-70. PubMed ID: 1686554
[TBL] [Abstract][Full Text] [Related]
4. Selection of a therapeutic agent for the treatment of chronic obstructive pulmonary disease in smokers.
Turino GM; Davies P; Dunlap R; Krell RD; Maycock AL; Rennard S; Stockley RA
Ann N Y Acad Sci; 1991 Dec; 624 Suppl():23-30. PubMed ID: 1686162
[No Abstract] [Full Text] [Related]
5. Revisiting alpha1-antitrypsin therapy in cystic fibrosis: can it still offer promise?
Brennan S
Eur Respir J; 2007 Feb; 29(2):229-30. PubMed ID: 17264320
[No Abstract] [Full Text] [Related]
6. [Elastase, elastase inhibitors and chronic obstructive lung diseases].
Kramps JA; Dijkman JH
Ned Tijdschr Geneeskd; 1990 Jun; 134(23):1127-30. PubMed ID: 2192289
[No Abstract] [Full Text] [Related]
7. Reduction in neutrophil elastase concentration by recombinant alphal-antitrypsin (recAAT) does not alter bacterial loading in the sputum of cystic fibrosis patients.
Moore JE; Shaw A; Millar BC; Martin SL; Murphy PG; Downey DG; Ennis M; Elborn JS
Br J Biomed Sci; 2004; 61(3):146-7. PubMed ID: 15462261
[No Abstract] [Full Text] [Related]
8. [Therapy of lung diseases with antiproteases].
Vogelmeier C; Buhl R
Pneumologie; 1994 Feb; 48(2):57-62. PubMed ID: 7910401
[TBL] [Abstract][Full Text] [Related]
9. Secretory leukoprotease inhibitor: partnering alpha 1-proteinase inhibitor to combat pulmonary inflammation.
Bingle L; Tetley TD
Thorax; 1996 Dec; 51(12):1273-4. PubMed ID: 8994529
[TBL] [Abstract][Full Text] [Related]
10. The protease-antiprotease battle in the cystic fibrosis lung.
Balfour-Lynn IM
J R Soc Med; 1999; 92 Suppl 37(Suppl 37):23-30. PubMed ID: 10472249
[No Abstract] [Full Text] [Related]
11. Novel therapeutic uses of alpha-1 antitrypsin: a window to the future.
Wanner A; Arce AD; Pardee E
COPD; 2012 Dec; 9(6):583-8. PubMed ID: 23205701
[TBL] [Abstract][Full Text] [Related]
12. Potential role of inhibitors of neutrophil elastase in treating diseases of the airway.
Chughtai B; O'Riordan TG
J Aerosol Med; 2004; 17(4):289-98. PubMed ID: 15684729
[TBL] [Abstract][Full Text] [Related]
13. Alpha-1 Antitrypsin Therapy in Cystic Fibrosis and the Lung Disease Associated with Alpha-1 Antitrypsin Deficiency.
McElvaney NG
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S191-6. PubMed ID: 27115956
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human leukocyte elastase bound to elastin: relative ineffectiveness and two mechanisms of inhibitory activity.
Morrison HM; Welgus HG; Stockley RA; Burnett D; Campbell EJ
Am J Respir Cell Mol Biol; 1990 Mar; 2(3):263-9. PubMed ID: 2310584
[TBL] [Abstract][Full Text] [Related]
15. Alpha1-proteinase inhibitor in the newborn - A comment.
Kirpalani H
Can Respir J; 1999; 6(2):136-7. PubMed ID: 10322095
[No Abstract] [Full Text] [Related]
16. Sharing a precious resource: an example of the promise of therapeutics for rare diseases to treat common conditions.
Walsh JW; Campber R
COPD; 2012 Dec; 9(6):581-2. PubMed ID: 23244168
[No Abstract] [Full Text] [Related]
17. alpha(1)-antitrypsin deficiency therapy : pieces of the puzzle.
Sandhaus RA
Chest; 2001 Mar; 119(3):676-8. PubMed ID: 11243938
[No Abstract] [Full Text] [Related]
18. Potential role of recombinant secretory leucoprotease inhibitor in the prevention of neutrophil mediated matrix degradation.
Llewellyn-Jones CG; Lomas DA; Stockley RA
Thorax; 1994 Jun; 49(6):567-72. PubMed ID: 7912452
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: enough is enough.
Balbi B; Ferrarotti I; Miravitlles M
Eur Respir J; 2016 Jan; 47(1):35-8. PubMed ID: 26721962
[No Abstract] [Full Text] [Related]
20. Inhibition of human neutrophil elastase-induced acute lung injury in hamsters by recombinant human pre-elafin (trappin-2).
Tremblay GM; Vachon E; Larouche C; Bourbonnais Y
Chest; 2002 Feb; 121(2):582-8. PubMed ID: 11834675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
